Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study

Epidemiological characterization of chronic myeloid leukaemia patients at an oncologic centre: A retrospective observational study

Background: The chronic myeloid leukaemia population, treatment patterns and responses in Portugal are unknown. The aim of this study is to describe these features in a Portuguese reference centre. Methods: A retrospective cohort study included patients with chronic myeloid leukaemia, treated betwee...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ana Maria Meireles, Rita Calisto, Maria José Bento, Pedro Martinho Gouveia, Susana Bizarro, Manuel Teixeira, Cláudia Moreira, Ana Espírito Santo, Mário Mariz
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	Hematology, Transfusion and Cell Therapy
Subjects:	Chronic myelogenous leukaemia BCR-ABL positive Imatinib mesylate Tyrosine kinase inhibitors Epidemiology Myeloproliferative disorders
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137925002032
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dasatinib: ten years of clinical practice worldwide
by: K. M. Abdulkadyrov, et al.
Published: (2016-03-01)

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib
by: Rima Hajjo, et al.
Published: (2025-06-01)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)

Cytogenetic landscape aberrations in paediatric acute lymphoblastic leukaemia — a polish paediatric population treated according to ALL-IC BFM 2009 protocol
by: Monika Lejman, et al.
Published: (2025-07-01)

Tyrosine kinase inhibitors therapy related neutropenia and thrombocythopenia correction in CML patients
by: V. A. Shuvaev, et al.
Published: (2014-07-01)

Chronic myeloid leukemia in childhood: a case report
by: Uma Bhatta, et al.
Published: (2021-09-01)

Rapidly Growing Gastrointestinal Stromal Tumor on the Esophagus
by: Ji Hye Park, et al.
Published: (2025-03-01)

The Unusual Presentation of Bilateral Proptosis Presents a Dilemma in the Case of Juvenile Myelomonocytic Leukemia
by: Himanshu Gohatre, et al.

Investigation of the anti-cancer drugs imatinib and thalidomide using analytical spectroscopy (FT-IR, UV-Vis) and molecular docking simulations
by: P. Venkata Ramana, et al.
Published: (2025-07-01)

Philadelphia chromosome-positive mixed-phenotype acute leukemia: a case report and literature review
by: Liqing Yang, et al.
Published: (2025-07-01)

Differential Molecular Diagnosis in Acute Myeloid Leukaemia: A Review
by: Ajayi O.I. , and Garba, N. *
Published: (2018-09-01)

A network-based approach to overcome BCR::ABL1-independent resistance in chronic myeloid leukemia
by: Valeria Bica, et al.
Published: (2025-04-01)

Paediatric acute myeloid leukaemia epidemiology, treatment approaches, and outcomes in africa: A review of the literature
by: Richard Nyeko, et al.
Published: (2025-07-01)

Somatically mutated ABL1 is an actionable and essential NSCLC survival gene
by: Ewelina Testoni, et al.
Published: (2016-01-01)

HEMATOLOGICAL MALIGNANCIES. LYMPHOCYTIC LEUKAEMIA
by: Peter F. Litvitsky, et al.
Published: (2016-11-01)

Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice
by: AG Turkina, et al.
Published: (2017-07-01)

An uneventful pregnancy and delivery, in a case with chronic myeloid leukemia on imatinib
by: Jovita Martin, et al.
Published: (2011-01-01)

Bilateral mandibular osteonecrosis associated with imatinib monotherapy for a patient with chronic myeloid leukemia
by: Yasuharu Yajima, et al.
Published: (2025-04-01)

Preventing and managing the toxicities associated with the combination therapy of ibrutinib and venetoclax in chronic lymphocytic leukaemia
by: Elżbieta Iskierka-Jażdżewska, et al.
Published: (2025-01-01)

The Role of STAT5 in Tyrosine Kinase Inhibitor (IMATINIB) Resistance in CML Patients
by: Anastasia Putri, et al.
Published: (2020-02-01)

Immunophenotypic Aberrancies in Acute Lymphoblastic Leukaemia: A Cross-sectional Study from a Tertiary Care Centre in Rajasthan, India
by: Shikha Goyal, et al.
Published: (2025-08-01)

Treatment of chronic lymphocytic leukaemia and autoimmune complications with antibody targeted to the CD52 antigen (Campath) - the first Russian experience
by: T. E. Byalik, et al.
Published: (2022-11-01)

Molecular targets for metastasis-directed therapy in malignant tumors
by: V. V. Bodenko, et al.
Published: (2024-07-01)

Stomach Cancer in a Patient with Chronic Lymphocytic Leukaemia
by: R. A. Maier, et al.
Published: (2019-07-01)

Current trends in the treatment of recurrent adenocystic cancer of the salivary glands: case report
by: O. A. Saprina, et al.
Published: (2023-03-01)

Leukemia cutis: a rare manifestation of an underlying primary plasma cell leukemia
by: Nutan Dixit, et al.
Published: (2023-12-01)

Characterisation of Cytotoxicity-Related Receptors on γδ T Cells in Chronic Lymphocytic Leukaemia
by: Michał Zarobkiewicz, et al.
Published: (2025-03-01)

The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad
by: Sandip A Shah
Published: (2013-01-01)

Predicting Binding Affinity of Some Imatinib Derivatives as BCR-ABL Tyrosine Kinase Inhibitors Based on Monte Carlo Optimization
by: Shahram Lotfi, et al.
Published: (2024-09-01)

Nafamostat Mesylate Regulates Glycosylation to Alleviate Aristolochic Acid Induced Kidney Injury
by: Pei Xie, et al.
Published: (2025-03-01)

Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia
by: Xiaokang Wang, et al.
Published: (2025-07-01)

Cytogenetic study of Acute myelogenous Leukemia in Erbil City-Iraqi Kurdistan Region
by: Kazhall Muhammad Sulaeman
Published: (2018-04-01)

Predictors Associated with Delayed Methotrexate Clearance among Patients with Haematological Malignancies
by: Muhammad Nasri Yusoff, et al.
Published: (2025-07-01)

Systems‐wide analysis of BCR signalosomes and downstream phosphorylation and ubiquitylation
by: Shankha Satpathy, et al.
Published: (2015-06-01)

HMGB1 as a biomarker for myeloproliferative neoplasm complicated with atherosclerosis
by: Lunbi Wu, et al.
Published: (2025-05-01)

Câhiliye Dönemi Şairlerinden Antere b. Şeddâd’ın Hayatı ve Edebi Kişiliği
by: Muharrem Ertaş
Published: (2021-03-01)

Early lymphocyte recovery after allogeneic transplantation of hematopoietic stem cells in patients with haematological malignancies: a single-centre experience
by: Kameliya Kostadinova, et al.
Published: (2025-08-01)

COMPARATIVE EFFICACY AND TOLERABILITY OF AVOCADO / SOYBEAN UNSAPONIFIABLES AND THEIR COMBINATION WITH INTRA-ARTICULAR HYALURONIC ACID IN PATIENTS WITH KNEE AND HIP OSTEOARTHROSIS
by: Ye. I. Shmidt, et al.
Published: (2014-11-01)

Inhibition of c-Abl suppresses the proliferation, invasion and migration of glioma cells
by: Fengqi Zhang, et al.
Published: (2025-08-01)

The course of rheumatoid arthritis in able-bodied persons
by: T M Chernykh, et al.
Published: (2011-12-01)